Determination of the activity of telomerase in cancer cells by using BSA-protected gold nanoclusters as a fluorescent probe
Authors:
- 27 February 2018
- journal article
- research article
- Published by Springer Nature in Microchimica Acta
- Vol. 185 (3) , 198
Abstract
Gold nanoclusters (AuNCs) protected with a bovine serum albumin (BSA) coating are known to emit red fluorescence (peaking at 650 nm) on photoexcitation with ultraviolet light (365 nm). On addition of Cu(II) ions, fluorescence is quenched because Cu(II) complexes certain amino acid units in the BSA chain. Fluorescence is, however, restored if pyrophosphate (PPi) is added because it will chelate Cu(II) and remove it from the BSA coating on the AuNCs. Because PPi is involved in the function of telomerase, the BSA@AuNCs loaded with Cu(II) can act as a fluorescent probe for determination of the activity of telomerase. A fluorescent assay was worked out for telomerase that is highly sensitive and has a wide linear range (10 nU to 10 fM per mL). The fluorescent probe was applied to the determination of telomerase activity in cervix carcinoma cells via imaging. It is shown that tumor cells can be well distinguished from normal cells by monitoring the differences in intracellular telomerase activity.Keywords
Funding Information
- National Natural Science Foundation of China
- Fund Project for Shangdong Key R&D Program
This publication has 33 references indexed in Scilit:
- Visual and fluorometric determination of telomerase activity by using a cationic conjugated polymer and fluorescence resonance energy transferMicrochimica Acta, 2017
- SERS assay of telomerase activity at single-cell level and colon cancer tissues via quadratic signal amplificationBiosensors and Bioelectronics, 2016
- Exonuclease I manipulating primer-modified gold nanoparticles for colorimetric telomerase activity assayBiosensors and Bioelectronics, 2016
- A PCR-free fluorescence strategy for detecting telomerase activity via double amplification strategyBiosensors and Bioelectronics, 2016
- Telomerase and cancer therapeuticsNature Reviews Cancer, 2008
- Targeting telomerase for cancer therapeuticsBritish Journal of Cancer, 2008
- Telomerase Maintains Telomere Structure in Normal Human CellsCell, 2003
- Telomerase RNA mutations in Saccharomyces cerevisiae alter telomerase action and reveal nonprocessivity in vivo and in vitro.Genes & Development, 1997
- Modifications of a telomeric repeat amplification protocol (TRAP) result in increased reliability, linearity and sensitivityNucleic Acids Research, 1995
- The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeatsCell, 1989